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Tuberculosis (TB) remains a significant global health 
problem. According to the 2013 Global Tuberculosis 
Report, an estimated 8.6 million people developed 
TB in 2012 and 1.3 million died from the disease.[1] 
An estimated 1.1 million (13%) of the 8.6 million 
people who developed TB in 2012 were HIV-positive, 75% of whom 
were from Africa. In 2012, approximately 450 000 people developed 
multidrug-resistant tuberculosis, of whom an estimated 170  000 
died. The majority of cases worldwide in 2012 were in South-East 
Asia (29%), Africa (19%) and the Western Pacific region (19%).[1] 
The TB incidence rate in South Africa (SA) is among the highest in 
the world, currently exceeding 1 000 cases per 100  000 people.[1,2] 
The predominant age group afflicted with TB is the second and third 
decades, with devastating socioeconomic implications.
The diagnosis of TB currently includes a detailed medical history, 
clinical examination, and radiological, microbiological, immunological, 
molecular and histological investigations. Culture-based detection of 
Mycobacterium tuberculosis (MTB) in sputa has remained the gold 
standard of diagnosis until recently, and sputum microscopy for acid-
fast bacilli (AFB) is the most commonly employed method of screening 
in the SA setting. However, culture of MTB takes an average of 2 or 
more weeks, and only 44% of all new cases (15 - 20% of children) are 
actually identified through the presence of AFB on sputum smears.[3] 
In the setting of TB and HIV co-infection, the sensitivity of sputum 
smear microscopy is even lower (~35%).[3] The high false-negative rate 
causes delays in diagnosis and therapeutic intervention, and may lead 
to further spread of the disease.
Definitive diagnosis of disseminated TB poses a challenge owing to 
atypical clinical presentations, and often a negative chest radiograph 
and negative findings on sputum microscopy and culture. This 
necessitates invasive procedures such as bone marrow aspiration 
(BMA), bone marrow trephine (BMT) biopsy, soft-tissue biopsy, 
lumbar puncture, etc.
TB culture is considered to be the gold standard for definitive 
diagnosis, but the turnaround time is undesirably long (up to 
6 weeks), which has an adverse impact on infection control.[3] 
Microscopic examination of the BMA smears and BMT biopsy 
specimens offers a far more rapid diagnostic strategy, where results 
can be available on the same day for the former and within 4 days 
for the latter. The diagnosis of TB in the bone marrow is made 
microscopically by the identification of granulomas and/or AFB 
by Ziehl-Neehlsen (ZN) staining in the BMT biopsy sections. ZN 
staining is not currently routinely performed on BMA samples owing 
to its low sensitivity. However, auramine O staining is reportedly 
more sensitive than ZN in sputum,[4] and may offer a higher yield in 
BMA samples as well.
Objective
To compare the diagnostic yield for TB between the BMA smear and 
BMT biopsy specimen against TB culture as the gold standard, and 
thereby identify a potentially faster and more effective diagnostic 
strategy for a resource-poor setting.
Methods
A retrospective 18-month review (January 2009 - June 2010) 
of bone marrow MTB test results was conducted at Chris Hani 
Baragwanath Hospital, a tertiary level hospital in Johannesburg, SA. 
The study was approved by the Human Research Ethics Committee 
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Background. Tuberculosis (TB) remains a global health problem. According to the 2013 Global Report on Tuberculosis, 8.6 million people 
developed TB in 2012 and 1.3 million died from the disease. An estimated 13% of people who developed TB in 2012 were HIV-positive, and 
75% of these lived in Africa. While pulmonary TB is the commonest form of Mycobacterium tuberculosis infection, extrapulmonary TB is 
increasingly being detected in HIV-positive patients. Definitive diagnosis of disseminated TB is a challenge owing to atypical presentations 
and diagnostic difficulties (negative chest radiograph and sputum microscopy and culture). A rapid diagnosis of disseminated TB is 
desirable, as early initiation of treatment can reduce mortality. Although TB culture is the gold standard for diagnosis of TB, it has a long 
turnaround time (up to 6 weeks).
Objectives. To identify a potentially faster and more effective diagnostic strategy for disseminated TB.
Methods. A retrospective 18-month review, conducted at a tertiary hospital, comparing histological findings of an auramine O-stained 
bone marrow aspiration (BMA) smear and a bone marrow trephine (BMT) biopsy specimen with the gold standard of TB culture.
Results. Microscopic examination of BMA smears and BMT biopsy specimens offers a rapid diagnostic strategy, with results available on 
the same day for the former and within 4 days for the latter. BMT histological examination had a significantly higher detection rate than 
BMA auramine O staining compared with TB culture.
Conclusion. We recommend that BMT biopsies remain an essential part of the diagnostic work-up for disseminated TB.
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of the University of the Witwatersrand (ethics number: M090688). 
The study population comprised 410 adult and paediatric patients 
who had a BMA smear and BMT biopsy specimen submitted for 
analysis to exclude MTB infection. Clinical data were obtained from 
the bone marrow request forms completed by clinicians, and results 
were retrieved from the laboratory information system (DisaLab 
version 04.16.04.373). BMA slides from BMA samples submitted to 
the National Health Laboratory Service (NHLS) for TB testing were 
stained with auramine O. The results of the latter were compared 
with those of BMT biopsy specimen microscopy and BMA TB 
culture.
BMA smears were stained with Giemsa for conventional 
microscopy and with auramine O for detection of AFB using 
fluorescent microscopy. BMT sections were stained with 
haemotoxylin and eosin for conventional microscopy. The presence 
of granulomas necessitated further staining for detection of infective 
organisms at the discretion of the reporting pathologist. TB culture 
was done on BMA samples inoculated into special Myco-Flytic 
culture vials during the BMA procedure. These were then incubated 
in the Bactec 9240 automated system and inspected weekly for 6 
weeks.
The diagnosis of bone marrow TB was made on the basis of one 
or more of the following criteria: (i) positive TB culture of bone 
marrow; (ii) detection of granulomas and/or AFB on the BMT biopsy 
specimen; and (iii) detection of AFB on the BMA sample using the 
auromine-O staining method.
Exclusion criteria were: (i) samples not inclusive of all test 
methods, viz. BMA auramine O staining, BMT biopsy specimen 
staining and TB culture; and (ii) suboptimal quality samples.
Statistical analysis
Statistical analysis was performed using STATISTICA software, 
version 12.0 (Stat Soft (Pty) Ltd). Data are presented as medians 
(interquartile range (IQR)) and proportions, as appropriate. 
Sensitivity and specificity were calculated for each test method using 
TB culture as the gold standard. The Mann-Whitney U-test was used 
to compare continuous variables of interest. The level of statistical 
significance was taken as p≤0.05.
Results
Characteristics of the cohort
Results from a total of 410 patient samples were analysed (Table 1).
Characteristics of patients diagnosed  
with tuberculosis
Out of the 410 patient samples, 123 were positive for TB. Of the 
samples in which a BMA/BMT biopsy was performed specifically 
to investigate for TB, 32.5% were positive for TB. The remainder of 
the patients with TB-positive samples had cytopenias (57.7%) and 
haematological malignancies (0.95%) (Table 2).
Of the 123 samples that were positive for TB, 7 (5.7%) were 
diagnosed on BMA auramine O staining, 97 (78.9%) had granulomas 
on the BMT biopsy specimen, and 63 (51.2%) were positive on TB 
culture. ZN staining was performed in only 90 cases (73.2%), and 
was found to be positive for AFB in 38 (42.2%). Sensitivity and 
specificity results for the various methods are set out in Table 3. 
The organism identified on TB culture was MTB in 58 (92%) of 
cases, and M. avium intracellulare complex in the remaining 5. All 
the BMA auramine O-positive cases with a positive TB culture were 
positive for MTB.
Of the 347 patients with samples negative for TB culture (84.6%), 
83 (23.9%) had TB diagnosed by examination of BMA/BMT biopsy 
specimens. This is an interesting finding with respect to TB culture 
being the gold standard. In contrast, of the 63 patients with positive 
TB culture results, 56 (88.9%) had a negative BMA auramine O stain, 
28 (44.4%) had no granulomas on the BMT biopsy specimen, and 20 
(of an available 37) (54.1%) were negative for AFB on ZN staining 
(Table 4).
In order to assess the value added by each of the four methods, 
test positivity rates in isolation were calculated, viz. TB culture n=24 
Table 1. Indications for bone marrow examination
Indications for bone marrow examination Requests, n (%)
Peripheral cytopenias 187 (45.6)
Haematological malignancies (lymphoma and 
leukaemia)
158 (38.5)
Suspected disseminated TB 65 (15.8)
Table 2. Characteristics of the cohort
Total sample size, N 410
Adults (>18 years), n 355
Paediatric patients (<18 years), n 55
HIV-positive patients in cohort, n/N (%)* 251/330 (76.1)
Patients diagnosed with TB† 123 (30.0)
Patients with peripheral cytopenia/s, n/N (%)‡ 71/123 (57.7)
Patients with clinical suspicion of disseminated TB, 
n/N (%)‡
40/123 (32.5)
Patients with suspected haematological 
malignancies, n/N (%)‡
12/123 (9.8) 
*Of patients tested for HIV.
†According to the inclusion and exclusion criteria listed under ‘Methods’.
‡Of the total number of TB-positive patients.
Table 3. Sensitivity and specificity of method against TB 
culture as reference method
Test Sensitivity, % Specificity, %
TB culture 100 100
BMT granuloma detection 56 82
ZN staining for AFB 46 94
BMA auramine O staining 9.3 99
Table 4. Relationship between TB culture (gold standard) and 
other methods (BMA auramine O stain, BMT ZN stain and 
BMT granulomas)
Diagnostic method positive TB culture negative, N=347 
(84.6%), n (%)
Auramine O stain (BMA) positive 1 (0.3)
Granuloma (BMT) positive 61 (17.6)
ZN stain positive 21 (6.1)
Diagnostic method negative TB culture positive, N=63 
(15.4%), n (%)
Auramine O stain (BMA) negative 56 (88.9)
Granuloma (BMT) negative 28 (44.4)
ZN stain negative 20 (31.7)
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(38.1%), BMT granulomas n=38 (39.2%), 
BMT ZN stain n=0 (0%), BMA auramine O 
stain n=0 (0%).
Characteristics of TB patients  
with HIV
Of the 330 patients tested for HIV, 251 
(76.1%) were HIV-positive. The number 
of dual HIV- and TB-positive patients was 
113/251 (45.0%). The sensitivity of TB 
detection in HIV-positive patients was best 
with BMT granuloma detection (56.9%) 
when compared with ZN staining (48.5%) 
and BMA auramine O staining (10.3%) 
against the gold-standard TB culture. In 
HIV-positive patients, the median CD4 
count was significantly lower in patients 
with TB than in those without TB: 33 
cells/µL (range 11 - 95) and 117 cells/µL 
(range 41 - 221), respectively (p<0.0001). 
Furthermore, the median CD4 count in 
patients with positive BMA auramine O 
staining was significantly lower (p<0.0001) 
than that in patients diagnosed with TB by 
any other modality, viz. 7 cells/µL (range 
4 - 16) and 35 cells/µL (range 15 - 98), 
respectively (p=0.022) (Table 5).
Discussion
TB remains a significant health problem, 
the detection of which requires prompt 
diagnosis. TB culture-based algorithms 
for diagnosis are relatively expensive[5] and 
have an unacceptably long turnaround 
time. Current rapid methods quoted in 
the literature include rapid liquid culture 
systems,[3] nucleic acid amplification tests[6] 
and the microscopic observation suscepti-
bility assay.[7] Studies have also recently 
shown that in HIV-positive patients with 
CD4 cell counts <100 cells/µL, the TB 
lipoarabinomannan urine test can detect 
over half of culture-positive TB patients in 
less than 30 minutes.[8] In the SA setting, 
the GeneXpert MTB/RIF assay has become 
widely available, and reportedly performs 
better than smear microscopy where TB and 
HIV are both highly endemic.[9] However, 
these tests are generally expensive and 
require specialised equipment and expertise, 
and to date none has been validated on BMA 
and BMT biopsy samples. In this study, we 
evaluated the role of BMT biopsy specimen 
examination and BMA auramine O staining 
in reducing the time taken to establish a 
diagnosis of disseminated TB, using TB 
culture as the gold standard.
Over 95% of the patients with disseminated 
TB were HIV-positive, with a median CD4 
count of 33 cells/µL. Approximately a third 
of these patients had a BMA/BMT biopsy 
performed to investigate for possible TB, 
and over half had unexplained cytopenias. 
The sensitivity for detecting TB was highest 
for histological examination of BMT biopsy 
specimens (56%), followed by ZN staining 
(46%), and least sensitive for auramine 
O staining of BMA samples (9.3%). 
Interestingly, the median CD4 counts in 
HIV-positive patients with TB diagnosed by 
auramine O staining of BMA samples were 
significantly lower than those in patients 
diagnosed with the other test methods, 
possibly reflecting a higher TB bacillary load 
as a consequence of immune compromise. 
Although the BMA auramine O method is 
rapid and showed excellent specificity, its 
sensitivity is too low for it to be advocated 
for routine practice. The reasons for the 
poor yield using this method are likely to 
be multifactorial, including poor quality 
of BMA samples, reduced macrophage 
activity on the BMA smear and overall poor 
sensitivity of the test method.
The utility of BMT biopsy specimen 
examination in the setting of HIV/
TB co-infected patients was reported on 
previously by Akpek et al.,[10] who showed 
that although the diagnostic sensitivity of 
bone marrow cultures was equal to that of 
blood cultures, histological examination of 
bone marrow resulted in rapid identification 
of nearly one-third of infected patients who 
underwent bone marrow examination, and 
that infection was identified in some patients 
who were culture-negative. In our study, 
examination of BMT biopsy specimens 
proved highly valuable; approximately half 
of the cases of TB were diagnosed micro-
scopically without a positive TB culture, 
and the diagnosis was expedited in over 
60% of patients in whom the TB culture 
was positive. Nevertheless, over one-third of 
patients with a positive TB culture had no 
bone marrow morphological abnormalities, 
highlighting the potential utility of mole-
cular techniques in this setting.
Conclusion
We found that histological examination of 
BMT biopsy specimens had a significantly 
higher detection rate than auramine O 
staining of BMA samples, compared with 
the gold-standard TB culture in our setting, 
where there is a high HIV burden. We 
recommend that BMT biopsies remain an 
essential part of the diagnostic work-up for 
disseminated TB. However, as microscopic 
examination failed (p<0.0001) to detect a 
substantial proportion of cases in whom 
TB culture was positive, other rapid 
molecular techniques such as GeneXpert 
are required. 
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Table 5. TB detection rates in HIV-positive patients
Tested for 
TB, N
Positive for 
TB, n (%)
CD4 count 
(cells/µL) (n=99), 
median (IQR)
HIV-positive patients tested for TB 251 113 (45.0) 33 (11 - 95) 
TB culture method 113 58 (51.3) 27 (9 - 82)
BMT granuloma detection 113 88 (77.9) 33 (14 - 81)
ZN staining for AFB (BMT) 83 36 (43.4) 28 (6 - 76)
BMA auramine O staining 113 7 (6.2) 7 (4 - 16)
